Sarcomi secondari del torace/della parete toracica: revisione della casistica dell’Istituto Ortopedico Rizzoli, trattamento chirurgico e outcomes clinici

Title

Code

Sarc Tor

Type

Osservazionale

Start Year

2022

Status

Terminato

Principal Investigator

051–6366211

fabio.davoli@ior.it

Davoli Fabio MD, PhD

Head

General & Thoracic Surgery Unit

Operational unit that carry out the study

departmental simple unit

Chirurgia Generale e Toracica

Head

Davoli Fabio MD, PhD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. Sarc Tor

Wednesday 14 December 2022, 15:49

PG0018305_2022_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Sarcomi secondari del torace/della parete toracica: revisione della casistica dell’Istituto Ortopedico Rizzoli, trattamento chirurgico e outcomes clinici

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Sarcomi secondari del torace/della parete toracica: revisione della casistica dell’Istituto Ortopedico Rizzoli, trattamento chirurgico e outcomes clinici

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in